Publication
Date
Link to Article
Israeli firm tests contact-free diagnostic tool for dialysis patients
Israeli firm PatenSee has launched the first human trial of its innovative contact-free surveillance tool to detect fistula stenosis, the narrowing of a certain blood vessel, in patients undergoing hemodialysis.
The system will be integrated into the dialysis center, and used in the waiting room with no interruptions to workflow and no intervention by medical staff.
The use of automated, machine-based solutions in healthcare has become a more prominent issue in the past year due to the coronavirus pandemic. As a result, finding an easy, reliable and contact-free early detection tool is essential for proper hemodialysis care.
Israeli firm PatenSee has launched the first human trial of its innovative contact-free surveillance tool to detect fistula stenosis, the narrowing of a certain blood vessel, in patients undergoing hemodialysis.
The system will be integrated into the dialysis center, and used in the waiting room with no interruptions to workflow and no intervention by medical staff.
The use of automated, machine-based solutions in healthcare has become a more prominent issue in the past year due to the coronavirus pandemic. As a result, finding an easy, reliable and contact-free early detection tool is essential for proper hemodialysis care.